<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="7647">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00905580</url>
  </required_header>
  <id_info>
    <org_study_id>IRB 4-2009-0070</org_study_id>
    <nct_id>NCT00905580</nct_id>
  </id_info>
  <brief_title>Perioperative Administration of Pregabalin for Pain After Robot-assisted Endoscopic Thyroidectomy</brief_title>
  <official_title>Perioperative Administration of Pregabalin for Pain After Robot-assisted Endoscopic Thyroidectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Severance Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Severance Hospital</source>
  <oversight_info>
    <authority>Korea: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize that pregabalin will decrease post-operative pain scores and
      analgesic use following robot-assisted endoscopic thyroidectomy compared to placebo. The
      primary outcome will be acute postoperative pain, measured by a verbal numerical rating
      score (VNRS) and total analgesic consumption during postoperative 48 hours. The secondary
      outcome will be the incidence of chronic pain and hypoesthesia in the anterior chest at 3
      months after operation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2009</start_date>
  <completion_date type="Actual">September 2009</completion_date>
  <primary_completion_date type="Actual">September 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Pain Scores (VNRS) at 1, 6, 24, 48 Hours Postoperatively.</measure>
    <time_frame>1, 6, 24 &amp; 48 hours</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>The Number of Participants With the Indicated Side Effects - Nausea &amp; Vomiting, Sedation, Headache, Dizziness Etc.</measure>
    <time_frame>1, 6, 24 &amp; 48 hours</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Patients Who Required Additional Analgesics During the First 48 Hours Postoperatively</measure>
    <time_frame>1, 6, 24 &amp; 48 hours</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Patients With Hypoesthesia in the Anterior Chest at 3 Months After Operation.</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">99</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients receive oral Placebo 150 mg 1 hour prior to surgery, and 12 hours later</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pregabalin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive oral pregabalin 150 mg 1 hour prior to surgery, and 12 hours later</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pregabalin</intervention_name>
    <description>Pregabalin 150 mg orally</description>
    <arm_group_label>Pregabalin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin Complex (placebo)</intervention_name>
    <description>Vitamin Complex 150 mg orally</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. American Society of Anesthesia physical status class I &amp; II

          2. Age ≥ 20 and ≤ 65 years

          3. Robot- assisted endoscopic thyroidectomy

        Exclusion Criteria:

          1. Known or suspected allergy, sensitivity, or contraindication to pregabalin or any of
             the standardized medications

          2. Body mass index ≥ 40 kg/m2

          3. History of seizure disorder

          4. Current therapy with pregabalin, gabapentin, or any opioid

          5. Any other physical or psychiatric condition which may impair their ability to
             cooperate with post-operative study data collection

          6. Insulin-dependent diabetes mellitus

          7. Renal insufficiency (estimated glomerular filtration rate (eGFR) &lt; 60 mL/min/1.73 m2)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute, Yonsei University College of Medicine</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>October 2009</verification_date>
  <lastchanged_date>January 15, 2010</lastchanged_date>
  <firstreceived_date>May 18, 2009</firstreceived_date>
  <firstreceived_results_date>October 13, 2009</firstreceived_results_date>
  <responsible_party>
    <name_title>Severance Hospital</name_title>
    <organization>Anesthesia and Pain Research Institute</organization>
  </responsible_party>
  <keyword>thyroidectomy</keyword>
  <keyword>pain, postoperative</keyword>
  <keyword>pregabalin</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pregabalin</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Placebo</title>
          <description>Patients receive oral Placebo 1 hour prior to surgery, and 12 hours later</description>
        </group>
        <group group_id="P2">
          <title>Pregabalin</title>
          <description>Patients receive oral pregabalin 1 hour prior to surgery, and 12 hours later</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="49"/>
                <participants group_id="P2" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="47"/>
                <participants group_id="P2" count="47"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Placebo</title>
          <description>Patients receive oral Placebo 1 hour prior to surgery, and 12 hours later</description>
        </group>
        <group group_id="B2">
          <title>Pregabalin</title>
          <description>Patients receive oral pregabalin 1 hour prior to surgery, and 12 hours later</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="49"/>
                <measurement group_id="B2" value="50"/>
                <measurement group_id="B3" value="99"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="49"/>
                <measurement group_id="B2" value="50"/>
                <measurement group_id="B3" value="99"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="38.5" spread="9.5"/>
                <measurement group_id="B2" value="38.0" spread="8.2"/>
                <measurement group_id="B3" value="38.2" spread="8.9"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="46"/>
                <measurement group_id="B2" value="48"/>
                <measurement group_id="B3" value="94"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="3"/>
                <measurement group_id="B2" value="2"/>
                <measurement group_id="B3" value="5"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Korea, Republic of</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="49"/>
                <measurement group_id="B2" value="50"/>
                <measurement group_id="B3" value="99"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Pain Scores (VNRS) at 1, 6, 24, 48 Hours Postoperatively.</title>
        <description>Pain was evaluated using an 11-point verbal numerical rating scale (VNRS). Patients were instructed preoperatively to express their pain on the 0–10 VNRS, where 0 means no pain at all, and 10 represents the worst pain imaginable</description>
        <time_frame>1, 6, 24 &amp; 48 hours</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Patients receive oral Placebo 1 hour prior to surgery, and 12 hours later</description>
          </group>
          <group group_id="O2">
            <title>Pregabalin</title>
            <description>Patients receive oral pregabalin 1 hour prior to surgery, and 12 hours later</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="47"/>
                  <measurement group_id="O2" value="47"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Pain Scores (VNRS) at 1, 6, 24, 48 Hours Postoperatively.</title>
            <description>Pain was evaluated using an 11-point verbal numerical rating scale (VNRS). Patients were instructed preoperatively to express their pain on the 0–10 VNRS, where 0 means no pain at all, and 10 represents the worst pain imaginable</description>
            <units>VNRS</units>
            <param>Median</param>
            <dispersion>Inter-Quartile Range</dispersion>
            <category_list>
              <category>
                <sub_title>1 Hour</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="6" lower_limit="5" upper_limit="8"/>
                  <measurement group_id="O2" value="6" lower_limit="4" upper_limit="8"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>6 Hour</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="3" lower_limit="2" upper_limit="4"/>
                  <measurement group_id="O2" value="2" lower_limit="1" upper_limit="3"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>24 Hour</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2" lower_limit="1" upper_limit="3"/>
                  <measurement group_id="O2" value="1" lower_limit="1" upper_limit="2"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>48 Hour</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2" lower_limit="1" upper_limit="2"/>
                  <measurement group_id="O2" value="1" lower_limit="1" upper_limit="1"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>The Number of Participants With the Indicated Side Effects - Nausea &amp; Vomiting, Sedation, Headache, Dizziness Etc.</title>
        <description>Nausea and vomiting was graded on a four-point scale, where 0 = no nausea, 1 = mild nausea, 2 = severe nausea requiring antiemetics, and 3 = retching and/ or vomiting. Grades 3 and 4 were grouped together as postoperative nausea and vomiting (PONV) and rescue anti-emetic, metoclopramide 10 mg i.v. was given. We asked patients about sedation, headache, dizziness, blurred vision.</description>
        <time_frame>1, 6, 24 &amp; 48 hours</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Patients receive oral Placebo 1 hour prior to surgery, and 12 hours later</description>
          </group>
          <group group_id="O2">
            <title>Pregabalin</title>
            <description>Patients receive oral pregabalin 1 hour prior to surgery, and 12 hours later</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="47"/>
                  <measurement group_id="O2" value="47"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>The Number of Participants With the Indicated Side Effects - Nausea &amp; Vomiting, Sedation, Headache, Dizziness Etc.</title>
            <description>Nausea and vomiting was graded on a four-point scale, where 0 = no nausea, 1 = mild nausea, 2 = severe nausea requiring antiemetics, and 3 = retching and/ or vomiting. Grades 3 and 4 were grouped together as postoperative nausea and vomiting (PONV) and rescue anti-emetic, metoclopramide 10 mg i.v. was given. We asked patients about sedation, headache, dizziness, blurred vision.</description>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <sub_title>PONV</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="10"/>
                  <measurement group_id="O2" value="7"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>headache</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="11"/>
                  <measurement group_id="O2" value="8"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>dizziness</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="6"/>
                  <measurement group_id="O2" value="14"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>sedation</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1"/>
                  <measurement group_id="O2" value="6"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>blurred vision</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0"/>
                  <measurement group_id="O2" value="3"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients With Hypoesthesia in the Anterior Chest at 3 Months After Operation.</title>
        <description>we checked Hypoesthesia in the anterior chest at 3 months after operation by phone.</description>
        <time_frame>3 months</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Patients receive oral Placebo 1 hour prior to surgery, and 12 hours later</description>
          </group>
          <group group_id="O2">
            <title>Pregabalin</title>
            <description>Patients receive oral pregabalin 1 hour prior to surgery, and 12 hours later</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="47"/>
                  <measurement group_id="O2" value="47"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Number of Patients With Hypoesthesia in the Anterior Chest at 3 Months After Operation.</title>
            <description>we checked Hypoesthesia in the anterior chest at 3 months after operation by phone.</description>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="13"/>
                  <measurement group_id="O2" value="10"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Patients Who Required Additional Analgesics During the First 48 Hours Postoperatively</title>
        <time_frame>1, 6, 24 &amp; 48 hours</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Patients receive oral Placebo 1 hour prior to surgery, and 12 hours later</description>
          </group>
          <group group_id="O2">
            <title>Pregabalin</title>
            <description>Patients receive oral pregabalin 1 hour prior to surgery, and 12 hours later</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="47"/>
                  <measurement group_id="O2" value="47"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Number of Patients Who Required Additional Analgesics During the First 48 Hours Postoperatively</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <sub_title>0-1 hour</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="31"/>
                  <measurement group_id="O2" value="26"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>1-6 hour</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="17"/>
                  <measurement group_id="O2" value="7"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>6 - 24 hour</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="15"/>
                  <measurement group_id="O2" value="2"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>24 - 48 hour</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="7"/>
                  <measurement group_id="O2" value="1"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Placebo</title>
          <description>Patients receive oral Placebo 1 hour prior to surgery, and 12 hours later</description>
        </group>
        <group group_id="E2">
          <title>Pregabalin</title>
          <description>Patients receive oral pregabalin 1 hour prior to surgery, and 12 hours later</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="47"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="47"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="47"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Sedation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="47"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="47"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="47"/>
              </event>
              <event>
                <sub_title>Blurred vision</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="47"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. So Yeon Kim</name_or_title>
      <organization>Department of Anaesthesiology and Pain Medicine and Anaesthesia and Pain Research Institute, Department of surgery, Yonsei University College of Medicine</organization>
      <phone>82-2-2227-3642</phone>
      <email>kimsy326@hanmail.net</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
